SCHEMBL7677616

SCHEMBL7677616

COc1cc2c(c(C(=O)Cl)c1OC)CCCC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
LMNA P02545 3/20 0.40
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38
TUBB8 Q3ZCM7 1/20 0.38
TUBA3E Q6PEY2 1/20 0.38
TUBA1A Q71U36 1/20 0.38
TUBA1C Q9BQE3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7676354 0.86 MEN1 (0.46) MEN1KMT2ALMNAPOLBTDP1
SCHEMBL7806894 0.82 KMT2A (0.49) MEN1KMT2ALMNAPOLBCYP1A2
SCHEMBL7681584 0.81 ALDH1A1 (0.37) MEN1KMT2ALMNAPOLBTDP1
SCHEMBL7675302 0.78 MEN1 (0.41) MEN1KMT2ALMNACYP1A2CYP2C19
SCHEMBL7681848 0.75 MEN1 (0.41) MEN1KMT2APOLBALDH1A1
SCHEMBL30888508 0.75 NOTUM (0.39) MEN1KMT2ALMNAALDH1A1SMN1; SMN2
SCHEMBL30888544 0.74 ALDH1A1 (0.43) MEN1KMT2ALMNAPOLBTDP1
SCHEMBL30888487 0.73 ALDH1A1 (0.50) MEN1KMT2ALMNAPOLBTDP1
SCHEMBL30888681 0.72 DHODH (0.36) MEN1KMT2ALMNACYP1A2CYP2C19
SCHEMBL30888484 0.72 TAS1R3 (0.42) MEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403601-B1 TREATMENT OF ASTHMA, ANXIETY, DEPRESSION, EMESIS, URINARY INCONTINENCE AND RELATED CONDITIONS. ASTRAZENECA AB (SE) 2002-06-11 US disclosed
EP-1137637-A1 N-(2-PHENYL-4-PIPERIDINYLBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-10-04 EP disclosed
WO-2000034243-A1 N-(2-PHENYL-4-PIPERIDINYBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-06-15 WO disclosed